07:00 , Apr 7, 2014 |  BC Week In Review  |  Financial News

Oncodesign completes IPO

Oncodesign S.A. (Euronext: ALONC), Dijon, France   Business: Cancer   Date completed: 3/27/14   Type: IPO   Raised: €12.3 million ($16.9 million)   Shares: 1.7 million   Price: €7.34   Shares after offering: 6.1 million...
00:46 , Apr 3, 2014 |  BC Extra  |  Financial News

Oncodesign, Genomic Vision price French IPOs

Oncodesign S.A. (Euronext:ALONC) and Genomic Vision S.A. (Euronext:GV) both raised money in IPOs on Euronext Paris. Oncodesign raised EUR 12.2 million ($16.8 million) through the sale of 1.7 million new shares at EUR 7.34, which...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Financial News

Oncodesign proposes IPO

Oncodesign S.A. , Dijon, France   Business: Cancer   Date announced: 2/7/14   Type: IPO   To be raised: Up to €10.7 million ($14.8 million)   Shares: 1.5 million   Price: €6.42-€7.34   Underwriters: CM-CIC...
23:39 , Mar 13, 2014 |  BC Extra  |  Financial News

Three French biotechs planning Euronext IPOs

Oncodesign S.A. (Dijon, France), Genomic Vision S.A. (Paris, France) and Genticel S.A. (Labege, France) are all planning IPOs on NYSE Euronext. Oncodesign is aiming to sell 1.5 million shares at EUR 6.42-EUR 7.34. At the...
07:00 , Oct 15, 2012 |  BC Week In Review  |  Financial News

Novacyt completes IPO

Novacyt S.A. , Vélizy-Villacoublay, France   Business: Supply/Service   Date completed: 10/8/12   Type: IPO   Raised: €2.6 million ($3.3 million)   Shares: 318,127   Price: €8.10   Shares after offering: 2.7 million   Note:...
01:18 , Oct 10, 2012 |  BC Extra  |  Financial News

French diagnostic firm Novacyt prices IPO

French diagnostic play Novacyt S.A. (Velizy-Veillacoublay, France) raised EUR 2.6 million ($3.3 million) through the sale of 318,127 shares at EUR 8.10 in an IPO on Euronext Paris and a concurrent private placement. The price...